CHAMPIONS ONCOLOGY, INC. (CSBR) Shareholders’ equity 2018–2026
CHAMPIONS ONCOLOGY, INC. (CSBR) shareholders’ equity at each fiscal year-end, per SEC filings.
$3.9MFY2026 · since FY2018: $3,000 → $3.9M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2026 | $3.9M | +4.4% |
| FY2025 | $3.8M | +298.2% |
| FY2024 | -$1.9M | -141.0% |
| FY2023 | $4.6M | -49.0% |
| FY2022 | $9.1M | +22.5% |
| FY2021 | $7.4M | +45.7% |
| FY2020 | $5.1M | +138.6% |
| FY2019 | $2.1M | +71133.3% |
| FY2018 | $3,000 | — |
Source: SEC XBRL filings · For reference only · Not investment advice